|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/22 | (2006.01) |
| G01N 33/74 | (2013.01) | ||
| A61K 38/08 | (2019.01) | ||
| A61P 9/02 | (2018.01) | ||
| A61K 31/137 | (2006.01) | ||
| A61K 38/085 | (2013.01) | ||
| A61P 9/02 | (2006.01) | ||
| G01N2410/02 | (2013.01) | ||
| G01N2800/32 | (2013.01) | ||
| G01N2800/52 | (2013.01) |
| (11) | Number of the document | 3400000 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17736407.2 |
| Date of filing the European patent application | 2017-01-06 | |
| (97) | Date of publication of the European application | 2018-11-14 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/012485 |
| Date | 2017-01-06 |
| (87) | Number | WO 2017/120438 |
| Date | 2017-07-13 |
| (30) | Number | Date | Country code |
| 201662276171 P | 2016-01-07 | US | |
| 201662347292 P | 2016-06-08 | US |
| (72) |
TIDMARSH, George , US
CHAWLA, Lakhmir , US
|
| (73) |
La Jolla Pharma, LLC ,
4550 Towne Centre Court, San Diego CA 92121,
US
|
| (54) | METHODS FOR ADMINISTERING ANGIOTENSIN II |
| METHODS FOR ADMINISTERING ANGIOTENSIN II |